Page 22 - Read Online

Cheng et al. J Cancer Metastasis Treat 2021;7:17 https://dx.doi.org/10.20517/2394-4722.2021.27 Page 17 of 18

in TGFβ-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues. J Nutr Biochem
2019;63:150-6. DOI PubMed PMC
44. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and
biomedical sciences. Behav Res Methods 2007;39:175-91. DOI PubMed
45. Pearse G, Frith J, Randall KJ, Klinowska T. Urinary retention and cystitis associated with subcutaneous estradiol pellets in female
nude mice. Toxicol Pathol 2009;37:227-34. DOI PubMed
46. Gakhar G, Wight-Carter M, Andrews G, Olson S, Nguyen TA. Hydronephrosis and urine retention in estrogen-implanted athymic
nude mice. Vet Pathol 2009;46:505-8. DOI PubMed
47. Wright LE, Frye JB, Timmermann BN, Funk JL. Protection of trabecular bone in ovariectomized rats by turmeric (Curcuma longa L.)
is dependent on extract composition. J Agric Food Chem 2010;58:9498-504. DOI PubMed PMC
48. Funk JL, Cordaro LA, Wei H, Benjamin JB, Yocum DE. Synovium as a source of increased amino-terminal parathyroid hormone-
related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the
pathogenesis of rheumatoid arthritis. J Clin Invest 1998;101:1362-71. DOI PubMed PMC
49. Dempster DW, Compston JE, Drezner MK, et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012
update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2013;28:2-17. DOI PubMed
PMC
50. Haider MT, Holen I, Dear TN, Hunter K, Brown HK. Modifying the osteoblastic niche with zoledronic acid in vivo-potential
implications for breast cancer bone metastasis. Bone 2014;66:240-50. DOI PubMed PMC
51. Streicher C, Heyny A, Andrukhova O, et al. Estrogen regulates bone turnover by targeting RANKL expression in bone lining cells. Sci
Rep 2017;7:6460. DOI PubMed PMC
52. Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simões MJ, Cerri PS. Biology of bone tissue: structure, function, and factors that
influence bone cells. Biomed Res Int 2015;2015:421746. DOI PubMed PMC
53. Brown HK, Ottewell PD, Evans CA, Holen I. Location matters: osteoblast and osteoclast distribution is modified by the presence and
proximity to breast cancer cells in vivo. Clin Exp Metastasis 2012;29:927-38. DOI PubMed
54. Meng X, Vander Ark A, Lee P, et al. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone
metastasis. Oncogene 2016;35:2370-8. DOI PubMed
55. Biswas S, Nyman JS, Alvarez J, et al. Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast
cancer metastasis to bone. PLoS One 2011;6:e27090. DOI PubMed PMC
56. Haisenleder DJ, Schoenfelder AH, Marcinko ES, Geddis LM, Marshall JC. Estimation of estradiol in mouse serum samples: evaluation
of commercial estradiol immunoassays. Endocrinology 2011;152:4443-7. DOI PubMed PMC
57. Bouxsein ML, Myers KS, Shultz KL, Donahue LR, Rosen CJ, Beamer WG. Ovariectomy-induced bone loss varies among inbred
strains of mice. J Bone Miner Res 2005;20:1085-92. DOI PubMed
58. Gérard C, Mestdagt M, Tskitishvili E, et al. Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may
provide a safe therapeutic window for the treatment of menopausal symptoms. Oncotarget 2015;6:17621-36. DOI PubMed PMC
59. Wright LE, Ottewell PD, Rucci N, et al. Murine models of breast cancer bone metastasis. Bonekey Rep 2016;5:804. DOI PubMed
PMC
60. Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metab 2012;23:576-81. DOI PubMed PMC
61. Fantozzi A, Christofori G. Mouse models of breast cancer metastasis. Breast Cancer Res 2006;8:212. DOI PubMed PMC
62. Powell GJ, Southby J, Danks JA, et al. Localization of parathyroid hormone-related protein in breast cancer metastases: increased
incidence in bone compared with other sites. Cancer Res 1991;51:3059-61. PubMed
63. Southby J, Kissin MW, Danks JA, et al. Immunohistochemical localization of parathyroid hormone-related protein in human breast
cancer. Cancer Res 1990;50:7710-6. PubMed
64. Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, Katzenellenbogen BS. Antagonists selective for estrogen receptor
alpha. Endocrinology 2002;143:941-7. DOI PubMed
65. Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS. Conformational changes and coactivator recruitment by novel
ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among
SRC coactivator family members. Endocrinology 2000;141:3534-45. DOI PubMed
66. Li S, Peng Y, Weinhandl ED, et al. Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin
Epidemiol 2012;4:87-93. DOI PubMed PMC
67. Mundy GR. Metastasis: metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2:584-93. DOI
PubMed
68. Svendsen H, Gammelager H, Sværke C, et al. Hospital visits among women with skeletal-related events secondary to breast cancer and
bone metastases: a nationwide population-based cohort study in Denmark. Clin Epidemiol 2013;5:97. DOI PubMed PMC
69. Haque R, Ahmed SA, Inzhakova G, et al. Impact of breast cancer subtypes and treatment on survival: an analysis spanning two
decades. Cancer Epidemiol Biomarkers Prev 2012;21:1848-55. DOI PubMed PMC
70. Colzani E, Johansson ALV, Liljegren A, et al. Time-dependent risk of developing distant metastasis in breast cancer patients according
to treatment, age and tumour characteristics. Br J Cancer 2014;110:1378-84. DOI PubMed PMC
71. Turner NC, Neven P, Loibl S, Andre F. Advances in the treatment of advanced oestrogen-receptor-positive breast cancer. Lancet
2017;389:2403-14. DOI PubMed
72. Portman N, Alexandrou S, Carson E, Wang S, Lim E, Caldon CE. Overcoming CDK4/6 inhibitor resistance in ER-positive breast
cancer. Endocr Relat Cancer 2019;26:R15-30. DOI PubMed